P oly(ADP-ribose) polymerase (Parp) catalyzes the poly(ADPribosyl)ation reaction of Parp itself and other nuclear proteins by using NAD as a substrate after activation by single-or double-strand breaks of DNA. Recent studies using Parp knockout mice and cells showed that Parp is involved in recovery from DNA damages and maintenance of genomic integrity (1-7). On the other hand, because poly(ADP-ribosyl)ation of nuclear proteins causes the accumulation of negative charges and conformational changes on acceptor proteins, it is suggested that poly(ADP-ribosyl)ation of proteins could affect the local chromosome organization and consequently alter various gene expressions. In fact, studies have indicated that Parp is involved in transcriptional regulation of genes (8-10) and cellular differentiation processes (11) (12) (13) (14) . Poly(ADP-ribose) synthesis dramatically decreases in teratocarcinoma EC-A1 cells during in vitro differentiation induced by retinoic acid (11). Furthermore, the teratocarcinoma cells undergo differentiation in vitro in the presence of the Parp inhibitor, 3-aminobenzamide (11). A potent Parp inhibitor, 5-iodo-6-amino-1,2-benzopyron, also induces the phenotypic reversions of tumorigenic endothelial cells transformed with H-ras and of prostate carcinoma cells (14). This evidence thus suggests that Parp could be involved in tumorigenesis through affecting cellular differentiation. However, be- 
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oly(ADP-ribose) polymerase (Parp) catalyzes the poly(ADPribosyl)ation reaction of Parp itself and other nuclear proteins by using NAD as a substrate after activation by single-or double-strand breaks of DNA. Recent studies using Parp knockout mice and cells showed that Parp is involved in recovery from DNA damages and maintenance of genomic integrity (1) (2) (3) (4) (5) (6) (7) . On the other hand, because poly(ADP-ribosyl)ation of nuclear proteins causes the accumulation of negative charges and conformational changes on acceptor proteins, it is suggested that poly(ADP-ribosyl)ation of proteins could affect the local chromosome organization and consequently alter various gene expressions. In fact, studies have indicated that Parp is involved in transcriptional regulation of genes (8) (9) (10) and cellular differentiation processes (11) (12) (13) (14) . Poly(ADP-ribose) synthesis dramatically decreases in teratocarcinoma EC-A1 cells during in vitro differentiation induced by retinoic acid (11) . Furthermore, the teratocarcinoma cells undergo differentiation in vitro in the presence of the Parp inhibitor, 3-aminobenzamide (11) . A potent Parp inhibitor, 5-iodo-6-amino-1,2-benzopyron, also induces the phenotypic reversions of tumorigenic endothelial cells transformed with H-ras and of prostate carcinoma cells (14) . This evidence thus suggests that Parp could be involved in tumorigenesis through affecting cellular differentiation. However, because Parp inhibitors have various side effects on cells (15) , it is not known whether Parp alone is involved in these phenomena. In addition, other Parp-related proteins, including Parp-2, Parp-3, and tankyrase, recently were found and reported to have poly(ADP-ribosyl)ation activity (16) (17) (18) (19) (20) . Tankyrase was shown to be inhibited by the classical Parp inhibitors (17) . Parp-2 and Parp-3 possibly could be inhibited by the classical Parp inhibitors. Therefore, Parp-disrupted cells and animals are useful as relevant experimental tools to elucidate the Parp function specifically.
In the present study, to clarify the effect of Parp disruption on tumorigenesis and cellular differentiation in vivo, Parp-deficient embryonic stem (ES) cell clones established by disrupting both alleles of Parp exon 1 by inserting neomycin-resistance gene and puromycin-resistance gene, respectively (21) , in wild-type J1 ES cells (22) were used. Mouse ES cells are potentially tumorigenic and develop into teratocarcinoma when injected into extrauterine sites in syngenic or nude mice (23) . Mouse ES cells also are known to participate in normal mouse embryonic development when injected into blastocyst and generally are understood to have no serious genetic changes (23) . Tumors derived from ES cells also might have no additional substantial genetic changes but could be associated with epigenetic changes as previously claimed by Mintz and Illmensee (24) . During teratocarcinoma formation in vivo, the differentiation potential of ES cells also could be analyzed.
Parp-deficient ES clones derived from J1 ES cells were injected s.c. into nude mice, and the growth and histological characteristics of the tumors were analyzed and compared with those of the wild-type J1 cells. Tumorigenicity was not lost in CO 2 -95% air in DMEM (GIBCO͞BRL) supplemented with 20% FBS, nonessential amino acids (GIBCO͞BRL), 55 M ␤-mercaptoethanol, 0.3 mM each of adenosine, guanosine, and thymidine, 0.1 mM uridine, and 10 3 units͞ml of mouse leukemia inhibitory factor (Amrad, Melbourne, Australia) on gelatincoated dishes (Iwaki, Chiba, Japan). Parp ϩ/Ϫ heterozygous ES cells analyzed in this study were clones 210 and 226. These ES clones were established by inserting neomycin-resistance gene in Parp exon 1. Parp Ϫ/Ϫ homozygous ES cells analyzed were clones 210-58 and 226-47, which were derived from Parp ϩ/Ϫ clones 210 and 226 by inserting puromycin-resistance gene in Parp exon 1, respectively, as described (4, 5, 21) .
Subcutaneous Injection of ES Cells into Nude Mice. ES cells were grown in the absence of a STO cell feeder layer on 100-mm culture plates to near 50% confluence, harvested with a cell scraper, then resuspended in PBS. Aliquots of 2 ϫ 10 6 ES cells of each Parp genotype were injected s.c. into both flanks of six 8-week-old female BALB͞c nu͞nu mice (CLEA Japan, Tokyo), and the animals were examined continuously over 3 weeks for the appearance and growth of tumors. Three weeks after injection of ES cells, mice were euthanized, and the weight of each tumor was determined immediately after resection. Differences in tumor weights were evaluated statistically by the MannWhitney U tests using the SPSS software (Macintosh version, SPSS, Chicago).
Morphological Analysis of Tumors. After resection of the tumors, they were fixed about 12 hr in neutralized 10% formalin solution and embedded in paraffin blocks by using standard procedures. Paraffin sections were stained with hematoxylin͞eosin, and histopathological analysis was performed under a light microscopic observation. For electron microscopic examination, ultrathin sections were prepared from tissues embedded in epon after fixation with 2% glutaraldehyde-phosphate buffer and 1% osmic acid (Merck), and the sections were stained with uranium acetate-lead. Electron microscopic examination was performed by using an H7000 electron microscope (Hitachi, Tokyo).
Immunohistochemical Staining. Tissue sections (5 m) were mounted on poly-L-lysine-coated slides, deparaffinized with xylene, and rehydrated with graded alcohol. After inactivating endogenous peroxidase with 0.3% hydrogen peroxide in methanol for 30 min and blocking with PBS containing 2% normal goat serum and 0.1% BSA for 30 min, sections were incubated for 12 hr at 4°C in a humidified chamber with polyclonal antibody against mouse prolactin (Biogenesis, Bournemouth, U.K.) diluted 200-fold in PBS containing 2% goat serum and 0.1% BSA. Biotinylated anti-rabbit IgG raised in goat (Vector Laboratories) was diluted 200-fold in PBS containing 2% goat serum and used as the secondary antibody. Staining was performed by using a Vectastain ABC kit (Vector Laboratories). The sections were counterstained with hematoxyline. As a negative control, duplicated sections were immunostained without exposure to the primary antibody. 
Results

Presence of STGCs and Extensive Hemorrhage in Tumors Derived from
Parp ؊/؊ Clones. As described in the previous section, the giant cells with single or multiple megalo-nuclei were present in tumors derived from Parp Ϫ/Ϫ clones 210-58 and 226-47, and these cells contained eosinophilic cytoplasm (Fig. 2B) . Microscopic examination showed that these giant cells were present in extensive intratumoral hemorrhage in all tumors derived from Parp clones. There was no hematopoiesis or vascular endothelial cell growth at the boundary of the hemorrhagic region. To get further information on the fine structure of these giant cells, electron microscopic examination was performed as shown in Fig. 3 . It revealed the presence of microvilli on the surface and secretion granules with high electron density in the cytoplasm, both of which are characteristically seen in trophoblasts in the normal placenta. These cells therefore were diagnosed as STGCs based on their characteristic features, namely the single or multiple megalonuclei, eosinophilic cytoplasm, microvilli on the cell surface, and the presence of secretion granules.
Because rodent trophoblastic cells are known to produce prolactin, prolactin-related protein, or placental lactogen (25) (26) (27) , the immunoreactivity of these STGCs to an antibody against mouse prolactin also was examined. As shown in Fig. 4 clones possess inserted neomycinand puromycin-resistance genes, which are not present in wildtype J1 cells. FGF-4 Ϫ/Ϫ ES clones were similarly established by inserting these two antibiotic resistance genes in R1 ES cells (31) , which are derived from the same 129͞Sv mouse strain as J1 cells. Therefore, it is unlikely that expressions of neomycin-and puromycin-resistance genes in ES cells resulted in the formation of STGCs in tumors. Taken together, the induction of STGCs observed in this study is likely to be related to the Parp disruption.
Except for the presence of STGCs, the differentiation profile of ES cells in tumor was not different among Parp genotypes. This finding is an apparent discrepancy with the result of Ohashi et al. (11) , who observed differentiation of teratocarcinoma EC-A1 cells by treatment with Parp inhibitor, 3-aminobenzamide. This discrepancy could be explained either by the low specificity of Parp inhibitors they used or the difference of the mice. The STGCs observed in this study are histologically different from the multinucleated keratinocytes because keratinocytes lack such secretion granules and microvillous cell surface. For the same reason, these cells could be distinguished from other kinds of giant cells such as megakaryoblasts or megakaryocytes. The further evidence of positive staining with mouse antiprolactin antibody, which also could stain trophoblasts in normal placenta, supports the idea that the STGCs belong to the trophoblast cell lineage.
It is noteworthy that the STGCs were detected inside of the hemorrhagic regions. Microscopic examination suggested that the hemorrhage could not have occurred at early stages of tumor development by, for example, damage of the vascular endothelial cell layer, a process known to occur along with tissue necrosis, because hemosiderin deposits or blood clots in the hemorrhagic areas was not observed. In addition, there was no hematopoiesis or vascular endothelial cell growth around the hemorrhagic region. Taken together, these observations suggest that the hemorrhage most likely represents a blood lake with continuous blood flow or recent bleeding. Because STGCs possess invasive characteristics like placental trophoblasts, which invade the uterine wall through the process of implantation and placental formation, the intratumoral hemorrhage observed in tumors derived from Parp Ϫ/Ϫ clones could be a secondary event after the appearance of STGCs and their invasion into the surrounding tissues.
The majority of STGCs contained single nuclei but some contained multinuclei. Syncytiotrophoblasts of rodent placenta give rise exclusively by continued rounds of DNA synthesis without intervening mitosis (endoreduplication) and have polytene chromosomes, although some cells are polyploid (33) . It is not elucidated whether the STGCs in teratocarcinoma are formed by similar process to syncytiotrophoblast formation in rodent placenta, including endoreduplication and karyokinesis, as described above or entirely different processes, including cell (36) , and a zinc finger transcription factor, Snail family protein (37) . A transcription factor AP2 is involved in teratocarcinoma formation (38) . Interestingly, Parp recently was found to possess coactivator function of AP2 and cooperate in transcriptional regulation (39) . Various studies also suggest that Parp is involved in transcription control of the genes (8 -10) . It is thus possible that loss of Parp affects the transcription of a certain subset of genes that control trophoblast cell differentiation. Additional studies should be conducted to elucidate the precise mechanisms of how the loss of Parp activity drives differentiation into the STGCs. This study further opens a question on the effect of Parp deficiency on placental formation and function in uterus during mouse development.
Tumorigenicity was not lost in Parp-deficient ES cells. There was no significant difference in the mean weight of the tumors derived from wild-type J1 cells and Parp Ϫ/Ϫ clones. However, because the tumors derived from Parp Ϫ/Ϫ clones contained large hemorragic areas, the tumor weight does not directly reflect tumor cell growth. The ratio of differentiated cells and undifferentiated embryonal carcinoma cells in parenchymatous region showed no difference between tumors derived from J1 cells and Parp Ϫ/Ϫ clones.
The appearance of STGCs in human trophoblastic or choriocarcinomatous germ cell tumor is known to be associated with metastasis and poor prognosis (40) . Therefore, Parp deficiency could confer more malignant phenotype in germ cell tumor as a consequence. We tried to compare metastasis frequency between tumors derived from J1 cells and Parp Ϫ/Ϫ clones. However, even 3 months after transplantation of ES cells, no metastasis was observed. Because s.c. tumors seem to have low tendency of metastasis in general, experiments should be further conducted by changing injection site of ES cells. The present model could provide us with a good tool to investigate the biological role and induction mechanism of STGCs in germ cell tumors. 
